To explore the effects of RNA interference targeting four different genes (VEGF, C-myc, Survivin, hTERT) on the growth and proliferation of nasopharyngeal carcinoma (NPC) CNE-2Z cells. Fluorescein-labeled short-hairpin (sh)RNA plasmids together and separately targeting VEGF, C-myc, Survivin and hTERT were built and respectively called plasmid-shVEGF-shC-myc-shSurvivinshhTERT, plasmid-shVEGF, plasmid-shC-myc, plasmid-shSurvivin, plasmid-shhTERT. These plasmids were respectively transfected into human NPC CNE-2Z cells and xenograft tumors in nude mice. The expression of plasmids in NPC CNE-2Z cells and xenograft tumors was observed. Cell proliferation was detected with MTT assay. The mRNA and protein expression were determined by real-time PCR and western blot, respectively. The effects of plasmids on the biological behavior of CNE-2Z cells were observed with transwell invision chamber models. Apoptosis was determined with flow cytometer. The inhibitory effect of plasmids on xenograft tumors was observed in nude mice. The plasmid containing four different shRNAs could significantly inhibit CNE-2Z cell proliferation and decrease invasion ability in vitro compared with plasmids with each single shRNA (Po0.05). The plasmid containing four different shRNAs could simultaneously downregulate VEGF, C-myc, surviving, hTERT mRNA and protein expression in the CNE-2Z cells. The multiple gene shRNA could more significantly induce cell apoptosis than each single shRNA, respectively (Po0.05). The combinative silencing of these four genes had a better inhibitory effect on xenograft tumors than the silencing of each single shRNA (Po0.05). RNA interference targeting multiple genes can effectively inhibit NPC proliferation and induce apoptosis, which provides an experiment basis for NPC gene therapy.
Introduction
Nasopharyngeal cancer (NPC) is a kind of common malignant tumor in Southern China with high incidence. At present, the treatment of NPC mainly depends on radiotherapy and sometimes combines with chemotherapy, immunotherapy, surgical management, traditional Chinese medicine and so on. However, local recurrence and distant metastasis easily occur after radiotherapy, NPC cells are not sensitive to chemotherapeutics and drugs can produce toxic and side effects, which will affect patients' prognosis. 1 Therefore, finding a new technology which possesses low toxicity, good therapeutic effect and strong specificity has important clinical significance.
RNA interference refers to post-transcriptive gene silencing. Many experiments have displayed that RNA interference targeting single gene can inhibit the growth and proliferation of tumor cells. 2 However, interference targeting a single gene has limitations in the prevention and treatment of cancer. 3 Little research has been done on RNA interference targeting multiple genes, especially more than three genes.
As we know that tumorigenesis results from multiple gene mutation, multiple gene silencing may have better therapeutic effects on malignant tumors than single gene silencing. To confirm our speculation, in this study, we built short-hairpin (sh)RNA plasmids together and separately targeting VEGF, C-myc, Survivin and hTERT, and respectively transfected these plasmids into human NPC CNE-2Z cells and xenograft tumors in nude mice to observe the effects of these plasmids on NPC.
Materials and methods
Cell line, animals and reagents NPC CNE-2Z cells were purchased from Kaiji Bio-Technology (Nanjing, China). Fetal bovine serum was purchased from Invitrogen (Carlsbad, CA). RPMI 1640 and 0.25% trypsin was purchased from Invitrogen. Lipo2000 was purchased from Ruibo (Guangzhou, China). Four-week-old female BALB/c nude mice weighing between 18 and 22 g with congenital cellular immune defect were purchased from Shanghai Animal Experimental Center of Chinese Academy of Science. Real-time PCR primers were synthesized by Shanghai Bioengineering (Shanghai, China). Primary antibodies of VEGF, C-myc, Survivin and hTERT, and polyclonal antibody of GAPDH (1:25 000) were purchased from Santa Cruz (Santa Cruz, CA). Apoptotic PI staining kit was from Sciencell (Carlsbad, CA).
Cell culture
Human NPC CNE-2Z cells were incubated in RPMI medium 1640 containing 10% fetal bovine serum, 100 U ml À1 penicillin and 100 mg ml À1 streptomycin sulfate in an atmosphere of 5% CO 2 at 37 1C. The cells in logarithmic growth phase were used for experiment.
Equipments
Electrophoresis apparatus, electrophoresis chamber and GelDoxXR imaging system were purchased from BIORAD (Hercules, CA). Cary 50 UV photometer was from Varian (Santa Clara, CA). Fluorescence microscope was purchased from Leica (Wetzlar, Germany). Real-time PCR instrument was made by Applied Biosystem (Carlsbad, CA) and flow cytometer was provided by Eppendorf (Hamburg, Germany).
Design and construction of shRNA plasmids Sequences of RNA interference targeting VEGF, C-myc, Survivin, hTERT including VEGF: 5 0 -AAACCTCACCA AGGCCAGCAC-3 0 (1366-1387 bp), C-myc: 5 0 -GGCGA ACACACAACGTCTT-3 0 (1623-1642 bp), Survivin: 5 0 -GC AGTTTGAAGAATTAACCC-3 0 (394-414 bp) and hTERT: 5 0 -GAGCCACGTCTCTACCTTG-3 0 (3043-3062 bp) were designed with VEGF, C-myc, Survivin and hTERT mRNA as target genes (GeneBank numbers were NM_003376, NM_34815, NM_001168 and NM_198253, respectively) according to multiple bio-information laws. Then Blast and single nucleotide polymorphism analysis were performed. Hairpin-like double-stranded oligo DNA was designed according to the information and synthesized by Wuhan Jingsai (Wuhan, China). Following reannealing, digestion, ligation into the vector, double-stranded oligo DNA was transformed into E.COLI DH5a and entered pGenesil plasmid to obtain shRNA eukaryotic plasmids with EGFP including plasmid-shVEGF, plasmid-shC-myc, plasmidshSurvivin and plasmid-shhTERT. The four pairs of shRNA were cloned into the plasmid with U6 promotor to obtain plasmid-shVEGF-shC-myc-shSurvivin-shhTERT containing four different genes. A base sequence, which had no homology with human gene was randomly selected to construct plasmid-NC. Plasmid-NC was served as negative control. NC gene sequence was 5-GACTTCATAAGGCG CATGC-3.
Grouping
In this study, there were negative control group (containing shRNA plasmid without any target gene, NC group), blank control group (containing serum-free and antibiotic-free RPMI-1640 without shRNA, BC group), group 1 (containing plasmids with four genes), group 2 (containing plasmids with single VEGF gene), group 3 (containing plasmids with single C-myc gene), group 4 (containing plasmids with single Survivin gene) and group 5 (containing plasmids with single hTERT gene).
Plasmid transfection
Two milliliters of CNE-2Z cells (0.5 Â 10 5 per ml) were inoculated in 6-well plate to incubate for 48 h. Solution A contained 100 ml of serum-free and antibiotic-free RPMI-1640 and 2 ml (2 mg ml
À1
) of plasmids in a 1.5 ml EP tube. Solution B contained 100 ml of serum-free and antibioticfree RPMI-1640 and 4 ml of Lipo 2000 in a 1.5 ml EP tube. Solution A was put into solution B and gently mixed at room temperature for 20 min, then was added into CNE-2Z cells in NC group, group 1, group 2, group 3, group 4 and group 5. However, 200 ml of serum-free and antibiotic-free RPMI-1640 was added into CNE-2Z cells in BC group. Fluorescence expression was observed under a confocal microscopy 24 h after conventional culture.
MTT assay CNE-2Z cells (2 Â 10 4 per ml, 150 ml) were inoculated into 96-well plate with five wells for each group. Plasmid transfection was carried out as previously described, then continued to be incubated. Culture medium was changed every 24 h. MTT (5 mg ml À1 , 20 ml) was added 20, 44, 68 and 92 h after transfection. Four hours later, the supernatant was removed, then 150 ml of dimethyl sulfoxide was added and mixed for 10 min followed by determining absorbance value (A value) at 492 nm with ELSA monitor.
Real time-PCR Cells in each group were collected 48 h after plasmid was transfected. Total RNA was extracted and adjusted to 1 mg ml
. Three wells were set for each sample including GAPDH, VEGF, C-myc, Survivin and hTERT primer ( Table 1 ). The solution without complementary DNA template was used as negative control. Amplification was performed with MJ Chromo reverse transcriptase PCR instrument (Life Technologies, Carlsbad, CA). Reaction Table 1 Sequences of endogenous reference, VEGF, C-myc, Survivin and hTERT primer 
Western blotting
Protein was collected 96 h after plasmid was transfected and stored at À80 1C for future use. In each group, 20 mg of total protein underwent 10% SDS-polyacrylamide, then was transferred onto nitrocellulose membrane followed by sealing using Tris buffer saline Tween 20 containing 5% dried skim milk and 0.05% Tween at 37 1C for 1 h. Following washing membrane, antibodies of VEGF, C-myc, Survivin and hTERT (1:1000) or abtibody of GAPDH (1:25 000) were added at 4 1C overnight. Then horseradish peroxidase-labeled immunoglobulin G (1:10 000) was added. Finally radiography was performed.
Grayscale scanning was carried out with Foretix 1D software (Phoretix International, Newcastle upon Tyne, UK). Protein expression was indicated with the gray-level ratios of VEGF, C-myc, Survivin and hTERT to GAPDH. The testing was performed in triplicate.
In vitro invasive assay
Digestive and re-suspended cells were collected 48 h after plasmid was transfected and adjusted to 0.15 g l
À1
. Matrigel (20 ml) was coated on the polycarbonate microporous membrane of Transwell system with a pore size of 8 mm at 37 1C for 30 min. The upper chamber of Transwell system was loaded with 100 ml (1 Â 10 8 per l) of the digested and re-suspended cells, and the lower chamber was loaded with 600 ml of the corresponding culture supernatant per well for incubation in an atmosphere of 5 1C CO 2 at 37 1C for 48 h. Testing was performed in triplicate in each group. The cells on the filter membrane were removed with cotton swabs. The cells to penetrate the membrane were fixed and stained with Gimsa solution. The number of invasive cells in the five random visual fields was counted under a microscope. The invasive ability of cells was indicated with the number of invasive cells.
Determining apoptosis with a flow cytometer Cells were digested with 0.2% trypsin 48 h after plasmid was transfected, and were made into single-cell suspensions by centrifugation for cell count. More than 10 6 cells were added into 1.5 ml tube for centrifugation at a rate of 500 r.p.m. at 4 1C. The supernatant was removed. The cells was washed with pre-cooling phosphate-buffered saline twice, then were resuspended with 100 ml of precooling l Â binding buffer. The cells were placed on ice after 5 ml of AnnexinV-FITC was added. Blank control group was set. The cells were stored in the dark for 10 min, then 400 ml of l Â binding buffer was added and mixed. The results were analyzed within 30 min. The testing was performed in triplicate.
Human NPC formation assay in nude mice A total of 56 four-week-old female BALB/c nude mice weighing between 18 and 22 g with congenital cellular immune defect were purchased from Shanghai Animal Experimental Center of Chinese Academy of Science. Nude mice were maintained under specific pathogen-free conditions. NPC CNE-2Z cells (0.2 ml, about 10 Â 10 6 cells) were subcutaneously injected into the right axilla of nude mice. From that time, the tumor-long (a) and short diameter (b) were measured every week. Two weeks later, the 56 nude mice were divided seven groups including group 1 (plasmid-shVEGF-shC-myc-shSurvivin-shhTERT), group 2 (plasmid-shVEGF), group 3 (plasmid-shC-myc), group 4 (plasmid-shSurvivin), group 5 (plasmid-shhTERT), NC and BC group. In BC group, 350 ml of physiological saline, although in other groups, plasmid (20 mg) þ transfection reagent (30 ml) þ serum-free and antibiotic-free RPMI-1640 (300 ml) were locally injected once every 2 days, a total of seven times. Tumor volume in each group was calculated according to the formula: V ¼ 1/6pab 2 . Two weeks after the end of treat ment, mice were killed. Tumor was taken to observed plasmid transfection and expression in tumor, simultaneously the tumor-inhibiting rate was calculated according to the following formula: tumor-inhibiting rate (%) ¼ (1Àmean tumor volume in experimental group/mean tumor volume in BC group) Â 100%. At the same time, paraffin sections of tumor tissue in each group were stained with TUNEL method according to kit instructions, and then were observed under microscope. Five visual fields were randomly selected from one section, and then the number of apoptotic cells in 100 cells were counted. The mean values were served as the apoptotic index of the section. The testing was performed in triplicate.
Statistical analysis
Experimental data were expressed as x ± s. Statistical treatment was performed with SPSS12.0 software (Somers, NY). Multi-factor variance test was used in the comparison between groups.
Results

Detection of plasmid transfection
Twenty four hours after plasmids were transfected into cells, green-fluorescent cells were not present in BC group, although in other groups, a lot of green-fluorescent cells were seen under fluorescence microscope. In NC group, cells grew well with a lot of adherent cells with green fluorescence. In group 1, 2, 3, 4, 5, a lot of floating, round, dead green-fluorescent cells was seen, especially in group 1 (Figure 1 ).
MTT assay
The values were significantly lower in group 1, 2, 3, 4, 5 than in BC group with Pp0.05. and the value was significantly lower in group 1 than in group 2, 3, 4, 5 with Pp0.05 48 h, 72 and 96 h after transfection. There was no statistical significance in A values at each time point (Table 2) .
Reverse transcriptase PCR Quantitative expression of mRNA of different genes in each group 48 h after transfection is shown in Table 3 . The inhibition ratios of VEGF mRNA in group 1 and group 2 were (76.47 ± 2.08) and (69.75 ± 3.05)%, respectively. The inhibition ratios of C-myc mRNA in group 1 and group 3 were (79.73 ± 3.01) and (77.43 ± 1.98)%, respectively. The inhibition ratios of Survivin mRNA in group 1 and group 4 were (80.89±2.35) and (73.92± 2.56)%, respectively. The inhibition ratios of hTERT mRNA in group 1 and group 5 were (74.60 ± 2.68) and (70.47 ± 2.87)%, respectively.
Western blot
The inhibition ratios of VEGF protein in group 1 and group 2 were (66.95 ± 2. 42) and (64.30 ± 3.13)%, respectively. The inhibition ratios of C-myc protein in group 1 and group 3 were (62.89±2.97) and (59.18±3.09)%, respectively. The inhibition ratios of Survivin protein in group 1 and group 4 were (79.48 ± 1.92) and (70.51 ± 2.56)%, respectively. The inhibition ratios of hTERT protein in group 1 and group 5 were (79.60 ± 1.87) and (76.33 ± 4.11)%, respectively (Figure 2 ).
In vitro invasive assay
The number of cells to penetrate the membrane in group 1 was significantly reduced compared with those in other groups 48 h after transfection (Po0.05). The number of cells to penetrate the membrane was less in group 2, 3, 4, 5 than in group BC (Po0.05). There was no statistical difference in the number of cells to penetrate the 
Flow cytometer
At 48 h after transfection, apoptosis was 5.3±1.26% in BC group, 7.4±1.02% in NC group, 37.6±0.94% in group 1, 20.6 ± 1.27% in group 2, 22.6 ± 0.98% in group 3, 23.7 ± 1.09% in group 4, 22.9 ± 1.31% in group 5.
There was no statistical significance in apoptosis between BC and NC group (P40.05). The apoptosis was higher in group 1, 2, 3, 4, 5 than in BC group (Po0.01). The apoptosis was higher in group 1 than in group 2, 3, 4, 5 (Po0.05) (Figure 4) . 
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In vivo anti-tumor experiment NPC CNE-2Z cells were successfully inoculated in all nude mice. One week later, subcutaneous tumor formed and gradually increased. After treatment, tumor growth was marked in BC and NC group, whereas in group 1, 2, 3, 4, 5, tumor growth was slow, especially in group 1. No mice died in each group during the experiment. Under fluorescence microscope, expression of green fluorescence in cancer tissue was seen in group 1, 2, 3, 4, 5 and NC group, but in BC group, no green fluorescence was seen ( Figure 5 ). The tumor volumes in each group are shown in Table 4 . By the end of the treatment, tumor growth was significantly inhibited in group 1, 2, 3, 4, 5 compared with BC group. Tumor-inhibiting rate was 82.40% in group 1, 46.24% in group 2, 48.47% in group 3, 51.93% in group 4 and 46.78% in group 5. TUNEL indicated that apoptotic index was 2.8% ± 1.12 and 3.7% ± 0.95 in BC and NC group, respectively; and in group 1, 2, 3, 4, 5, apoptotic index was 49.8±1.98, 21.5%±2.31, 23.8%±1.98, 19.9% ± 2.75 and 24.60% ± 3.09, respectively. We can see the induction-apoptotic effect in group 1, 2, 3, 4, 5, but the effect is the most marked in group 1.
Discussion
RNA interference (RNAi) is a kind of gene silencing technique. As it can interfere with important molecules, which are involved in many diseases including tumor, possesses high specificity and targeting ability, RNAi may be used as a powerful research tool in the study of functional genomics. 4 Since Elbashir et al. 5 first used 19-23-nucleotides double-stranded small molecule to interfere with RNA (small interfering RNA) and successfully induced gene silencing in mammalian cells in 2001, RNAi technique has been widely used in functional analysis of mammalian genes in vitro and in vivo experiments. 6 At present, there are some studies mainly about single-gene interference in China, but the effect of single gene silencing is very limited. Although single gene silencing exhibits a certain effect on tumor, the therapeutic effects are not ideal. 7 Multiple gene mutation, multiple steps and multiple factors together lead to tumor, so interference with multiple genes will become an important issue in RNAi research. RNAi with multiple genes is a new direction of gene therapy for tumor, and may be a hope of treatment of malignant tumors.
VEGF expression is strongly associated with tumor vessel density and may be served as a marker to evaluate prognosis. Blocking VEGF expression can inhibit tumor growth and prevent tumor metastasis. 8 Interference with VEGF activity and prohibiting the combination of VEGF with its receptor can prevent and treat tumor. 9 There are VEGF expression in many tumors in animal and human. VEGF expression is more in NPC because it contains rich vessels. Therefore, VEGF was served as an interference site in this study. C-myc is a cell cycle-dependent oncogene and has an important role in cell proliferation and differentiation. C-myc is closely related to occurrence and development of tumor and has a strong influence on invasion and adhesion of tumor cells. 10 RNAi targeting C-myc has become a focus in gene therapy for many malignant tumors. 11 Survivin gene is a new member of Nasopharyngeal carcinoma Y Song et al apoptosis inhibitory protein gene family. It has become one of the tumor-specific genes and is regarded as a target molecule in tumor therapy due to its important role in apoptosis and proliferation of tumor cells. 12 A lot of attention has been paid to survivin because it is nearly present in all human tumor tissue 13 and absent in most normal tissue. It has been confirmed that telomerase has an important role in the occurrence and development of tumor, reduction of telomerase activity may significantly inhibit tumor cell growth and induce apoptosis.
14 The activation of telomerase can lead to uncontroled proliferation of malignant tumor, while hTERT gene is a ratelimiting factor in telomerase synthesis, so that hTERT gene is more closely associated with tumor. 15 It has been described that telomerase activity is present in more than 90% malignant carcinoma and absent in most benign lesions. 16, 17 Positive telomerase activity is present in more than 80% NPC. RNAi targeting telomerase or its subunit TERT has become a focus in gene therapy for malignant tumors. 18 VEGF, C-myc, Survivin and hTERT may be ideal target genes and will obtain better therapeutic effect in gene therapy for NPC. To study the effects of multi-gene silencing on malignant tumor, we constructed shRNA plasmids together and separately targeting VEGF, C-myc, Survivin and hTERT and transfected them into CNE-2Z cells.
Transfected CNE-2Z cells were observed under confocal microscopy and a lot of cells with green fluorescent (about 50%) were seen, demonstrating that plasmids were successfully transfected into CNE-2Z cells. MTT assay and in vitro invasive assay indicated that cell proliferation was significantly inhibited and in vitro invasive ability was significantly decreased after transfection in group 1, demonstrating that the plasmid together targeting VEGF, C-myc, Survivin and hTERT is better than the plasmid separately targeting VEGF, C-myc, Survivin and hTERT in inhibiting CNE-2Z cell growth and decreasing invasive ability. Reverse transcriptase PCR and western blot indicated that mRNA and protein expression of single gene were decreased in group 2, 3, 4, 5, whereas in group 1, mRNA and protein expression of four genes all were decreased, demonstrating that the effect of multi-gene silencing is stronger than single gene silencing, namely that simultaneous multi-gene silencing is better than single gene silencing in inhibiting tumor cell proliferation. Flow cytometry and in vivo anti-tumor experiment indicated that multi-gene silencing was better than single gene silencing in inhibiting tumor cell proliferation and inducing apoptosis.
A study has shown that three-gene silencing is better than single gene silencing in inhibiting HIV-1 cell growth and inducing apoptosis. 19 Hong et al. 20 have found that simultaneous C-myc and stat3 gene silencing is better than single C-myc or stat3 gene silencing in inhibiting growth and proliferation of melanoma cella. Yan Wang et al. 21 has found that three-gene silencing is better than single gene silencing in inhibiting Hep-2 cell growth and proliferation, which is consistent with our results. In this study, reverse transcriptase PCR and western blotting indicated that mRNA and protein of the four genes were all decreased after simultaneous four-gene silencing, demonstrating that constructed plasmids can simultaneously inhibit the four target genes. In vivo anti-tumor experiment also indicated that simultaneous four-gene silencing effectively inhibited tumor cell growth. The four genes may have synergetic effect during occurrence and development of tumor.
This study confirms that RNAi together targeting four different genes can better inhibit NPC CNE-2Z cell proliferation and induce apoptosis. We believe that the four genes are together involved in occurrence and development of NPC and have synergetic effect. Simultaneous four-gene silencing can more effectively inhibit tumor growth and induce apoptosis. This mechanism remains to be further studied. Simultaneous multi-gene silencing is a new strategy for tumor therapy. This study provides a new method for NPC gene therapy.
